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Introduction: This is the first study evaluating the interactions of human adipose tissue derived stem cells (ADSCs)
and human squamous cell carcinoma cells (SCCs), with regard to a prospective cell-based skin regenerative therapy
and a thereby unintended co-localization of ADSCs and SCCs.
Methods: ADSCs were co-cultured with A431-SCCs and primary SCCs (pSCCs) in a transwell system, and cell-cell
interactions were analyzed by assessing doubling time, migration and invasion, angiogenesis, quantitative real time
PCR of 229 tumor associated genes, and multiplex protein assays of 20 chemokines and growth factors and eight
matrix metalloproteinases (MMPS). Results of co-culture were compared to those of the respective mono-culture.
Results: ADSCs’ proliferation on the plate was significantly increased when co-cultured with A431-SCCs (P = 0.038).
PSCCs and ADSCs significantly decreased their proliferation in co-culture if cultured on the plate (P <0.001 and
P = 0.03). The migration of pSCC was significantly increased in co-culture (P = 0.009), as well as that of ADSCs in
A431-SCC-co-culture (P = 0.012). The invasive behavior of pSCCs and A431-SCCs was significantly increased in
co-culture by a mean of 33% and 35%, respectively (P = 0.038 and P <0.001). Furthermore, conditioned media
from co-cultured ADSC-A431-SCCs and co-cultured ADSCs-pSCCs induced tube formation in an angiogenesis
assay in vitro.
In A431-SCC-co-culture 36 genes were up- and 6 were down-regulated in ADSCs, in A431-SCCs 14 genes were
up- and 8 genes were down-regulated. In pSCCs-co-culture 36 genes were up-regulated in ADSCs, two were
down-regulated, one gene was up-regulated in pSCC, and three genes were down-regulated. Protein expression
analysis revealed that three proteins were exclusively produced in co-culture (CXCL9, IL-1b, and MMP-7). In
A431-SCC-co-culture the concentration of 17 proteins was significantly increased compared to the ADSCs
mono-culture (2.8- to 357-fold), and 15 proteins were expressed more highly (2.8- to 1,527-fold) compared to
the A431-SCCs mono-culture. In pSCC-co-culture the concentration of 10 proteins was increased compared to
ADSCs-mono-culture (2.5- to 77-fold) and that of 15 proteins was increased compared to pSCC mono-culture
(2.6- to 480-fold).
Conclusions: This is the first study evaluating the possible interactions of primary human ADSCs with human SCCs,
pointing towards a doubtlessly increased oncological risk, which should not be neglected when considering a
clinical use of isolated human ADSCs in skin regenerative therapies.* Correspondence: eva.koellensperger@ethianum.de
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Skin therapies based on adipose tissue derived stem cells
(ADSCs) are becoming more and more attractive, regard-
ing the possible positive effects of mesenchymal stem cells
on skin cells, such as an increase in collagen content, an
improvement of nutrition by increased angiogenesis, a
“whitening” effect through inhibition of tyrosine kinase
effect, a reduced apoptosis and a UV-protection of der-
mal fibroblasts [1-5]. ADSCs have been shown to se-
crete various growth factors that transmit these effects
through a paracrine fashion. This mechanism, however,
allows ADSCs to interact with tumor cells, too [6,7].
Cancer-associated fibroblasts (CAFs) have been shown
to be a crucial component in tumor cell proliferation,
cancer invasion and progression by secreting various
growth factors, cytokines and proteases into the tumor
microenvironment [8]. Since the origin of CAFs is dis-
cussed controversially and bone marrow-derived mes-
enchymal stem cells have also been suggested to be a
potential source of CFAs, the question arises of what
would happen if ADSCs were injected within the vicinity
of local tumor cells, such as skin tumor cells. While one
would avoid purposefully injecting ADSCs in a visible skin
tumor, of course, an unintended injection of ADSC adja-
cent to subclinical skin tumor cells is conceivable.
The squamous cell carcinoma is the second-most com-
mon skin tumor with a rising incidence of 25/100,000
people in Europe at the moment [9]. So far squamous cell
carcinoma cells (SCCs) have not yet been analyzed in this
context. Considering the rising use of fat and stem cell-
enriched fat as well as the proposed use of isolated
ADSCs, for example, in skin regenerative therapies, it is
necessary to analyze the possible interactions of human
ADSC with human squamous cell carcinoma cells.
To gain further insight in respect to such interactions,
we co-cultured primary human ADSCs and primary
SCCs or A431-SCCs cells. We then analyzed the pro-
teins secreted in their shared media, quantified the
changes in proliferation, migration, invasion, angiogen-
esis and the gene expression of each cell type and com-
pared each of the results to that of a mono-culture of
the same cell type.
Methods
All chemicals, if not noted separately, were purchased
from Sigma-Aldrich, Munich, Germany.
Donor specification
This study was conducted under the guidelines and
with the approval of the ethical committees of the
University of Heidelberg and of the medical association
of the local district of Baden-Wuerttemberg, Germany.
After the authors received informed consent, freshly
excised subcutaneous adipose tissue of six women withan age-range of 24 to 48 years (median age 37.5 years)
undergoing elective plastic surgery was used for isola-
tion of ADSCs.
ADSCs isolation and culture
Isolation of ADSCs
ADSCs were isolated from freshly excised subcutaneous
adipose tissue or liposuction using a procedure modified
from Hauner et al. [10]. In brief, the adipose tissue was
washed in 1% bovine serum albumin (BSA)/phosphate-
buffered saline (PBS), minced and digested enzymatically
by collagenase (collagenase CLS; 220 U/mg, Biochrom
AG, Berlin, Germany, 1.5 mg/ml, in 1% BSA/Krebs-
Ringer-solution) for 45 minutes under constant shaking
at 37°C. Mature adipocytes and connective tissue was
separated by centrifugation (700 × g, seven minutes at
room temperature). The sedimented cells were resus-
pended, passed through a 100 μm mesh filter (Neolab,
Heidelberg, Germany) and washed twice with 1% BSA/
PBS. After erythrocyte lysis (three minutes, 155 mM
ammoniumchloride, 10 mM potassium bicarbonate, 0.1 mM
EDTA) cells were washed again twice and plated at a
density of 2 × 104 cells/cm2 in an expansion medium
(see below). After 24 hours the medium was changed to
remove non-adhered cells.
Expansion of ADSCs
ADSCs were cultivated in an expansion medium consisting
of 60% Dulbecco’s modified Eagle’s medium (DMEM) low
glucose (1 g/l D-glucose) (Invitrogen, Life Technologies,
Darmstadt, Germany), 40% MCDB-201, 1 × ITS (insulin
transferrin selenous acid) (Becton Dickinson, Heidelberg,
Germany), 10−8 M dexamethasone, 0.1 mM ascorbic
acid-2-phosphate, 2% fetal calf serum (FCS) (Biochrom),
100 U/ml penicillin (Biochrom), 0.1 mg/ml streptomycin
(Biochrom), 10 ng/ml rhEGF and 10 ng/ml rhPDGF-BB
(CellSystems, Troisdorf, Germany). The medium was
changed every other day. Once the cells reached 70%
confluence they were detached with 0.25% trypsin-EDTA
(Biochrom) and replated with 3.5 × 103 cells per cm2.
ADSCs were incubated at 37°C with 5% CO2 and cultured
to passage four.
Determination of ADSCs stemness
Adipogenic differentiation and oil red staining
ADSCs were seeded in expansion medium at a density
of 24,000 cells/cm2. After reaching 90% confluence, adi-
pogenesis was induced by the alternated use of basal
medium (10% FCS/DMEM) supplemented with IDI-
mix (500 μM 3-isobutyl-1-methylxanthine; 1 μM dexa-
methasone; 1 μM indomethacin) for two days followed
by basal medium plus 10 μg/ml insulin for one day. The
induction cycle was repeated three times. To confirm
the successful adipogenic differentiation, cytoplasmic
Koellensperger et al. Stem Cell Research & Therapy 2014, 5:65 Page 3 of 18
http://stemcellres.com/content/5/3/65triglyceride lipid droplets were stained with the Oil Red
O staining method as described previously [11].
Osteogenic differentiation and alizarin red staining
After seeding with a density of 24,000 ADSC/cm2, cells
were grown in expansion medium to 90% confluence.
Osteogenic induction was initiated by changing the
medium to DMEM containing 10% FCS, supplemented
with 50 μM L-ascorbate-2-phosphate, 0.1 μM dexa-
methasone and 10 mM β-glycerophosphate disodium
salt. On Day 42 calcium deposition was demonstrated
histochemically by alizarin red staining as follows:
monolayers of mineralized mesenchymal stem cells
were washed twice with excess PBS and fixed with
pre-chilled 70% ethanol for one hour at −20°C. After a
short washing step with H2O, the cell layer was incu-
bated with 40 mM alizarin red (pH 4.2) for one minute
at room temperature. After aspiration of unincorporated
dye, cells were washed twice with H2O and once with
PBS before microscopic analysis.
Flow cytometry
ADSCs expanded to passage four were examined for sur-
face marker expression using flow cytometry. The following
monoclonal antibodies conjugated to fluorochromes were
used: anti-CD13-APC, anti-CD29-PE, anti-CD31-FITC,
anti-CD34-FITC, anti-CD44-APC, anti-CD45-FITC, anti-
CD49a-PE, anti-CD63-FITC,-anti-CD73-PE, anti-CD90-APC,
anti-CD105-FITC, anti-CD106-APC and anti-CD-166-
PE (all from Becton Dickinson, Heidelberg, Germany).
Isotype antibodies were included for all fluorochromes.
Cells were detached with 0.25% trypsin-EDTA, incu-
bated with directly conjugated MAbs in FACS-buffer
(1% FCS, 0.1% NaN3 in PBS) for 30 minutes on ice,
washed twice with FACS buffer, and fixed with 1% para-
formaldehyde/PBS. Cells were analyzed using a FACS-
Canto flow cytometry system (Becton Dickinson). Data
acquisition was performed with Diva software (Becton
Dickinson) and data were analyzed using FCS express
V3 (De Novo Software).
ADSC-SCC-co-culture
A431-SCCs were purchased from American Type Culture
Collection (ATCC), Manassas, VA, USA, Catalog nr. CRL-
1555. Primary SCCs from three different donors (two
males, one female, median age 50 years) were purchased
from Celprogen, San Pedro, CA, USA (Catalog nr. 36128–
10). The primary SCCs were pooled initially, cultured for
two passages and then applied to the co-culture system.
Co-culture of tumor cells and ADSCs was performed in
a transwell system. For that either 2 × 104 SCCs or 2 ×
104 ADSCs were seeded onto a polyester membrane
transwell-clear insert (Corning, pore size 0.4 μm) while
the corresponding other cell type was seeded onto thebottom of a six-well cell culture plate in the same cell
density. Cells were cultured up to five days in 4 ml expan-
sion medium per well without medium change. Each day
cell culture supernatants were harvested and the cell num-
ber was determined after trypzinization and trypan blue
staining. SCCs as well as ADSCs alone - either in transwell
inserts or on six-well culture plates - served as controls
and were treated like the co-culture. For further analysis
the exponential growth phase of the cells was determined
and the supernatants of Day 4 were analyzed in a protein
assay (human cytokine magnetic 30-Plex panel) while the
corresponding cells were used for gene expression studies.
Determination of cell proliferation
In order to obtain separate growth kinetics during the ex-
ponential growth phase for both, separately and co-
cultured cells, cells of nine wells per condition (ADSCs
alone, SCCs alone (A431- or primary SCCs), and both cell
types in co-culture) were harvested with trypsin/EDTA
once every 24 hours from Day 1 to Day 5. The cells were
stained with trypan blue and the viable cells were counted
with a Neubauer chamber. The generation time was calcu-
lated by the formula: G (hours) = (log2 × T)/(logY - logX)
with T = time in culture (hours), Y = number of cells at the
end of T, X = number of cells at the beginning of T. The
results were evaluated using Student’s t-test.
Analysis of cell migration
In order to determine the migration capacity of ADSC
and SCCs alone (A431- or primary SCCs) and in co-
culture, the QCM 24-Well Colorimetric Cell Migration
Assay (Merck Millipore) was performed. For this pur-
pose, cells of each cell type were seeded in expansion
medium either on the bottom of the supplied 24-well
plate (4,000 cells per well) or onto the membrane of the
transwell insert (3,500 cells per insert). Cells were cul-
tured separately for 24 hours before co-culture condi-
tions (ADSCs on the well plate bottom, SCCs in the
transwell inserts and vice versa) were established for a
further 24 hours. Both cell types alone in the inserts served
as controls. For evaluation of the assay, the medium
was removed and the inserts transferred into new wells
containing 400 μl cell stain for 20 minutes. The inserts
were washed with water and the non-migrated cells
were removed from the interior of the inserts with
cotton-tipped swabs. The dried inserts were transferred
into 200 μl of Extraction Buffer for 15 minutes and the op-
tical density of 100 μl extracted dye was measured at
560 nm. The results were evaluated using Student’s t-test.
In vitro analysis of invasive behavior
The invasion capacity of ADSC and SCCs was tested in
a Cell Invasion Assay Kit (QCM ECMatrix Cell Invasion
Assay, Merck Millipore). Cells of each cell type were
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the supplied 24-well plate (4,000 cells per well) or onto
the membrane of the transwell insert (3,500 cells per in-
sert). Cells were cultured separately for 24 hours
(ADSCs) or 72 hours (SCCs) before co-culture - ADSCs
on the bottom and SCCs in the inserts and vice versa -
was induced for a further 72 hours. Both cell types alone
in the inserts served as controls. Next, the medium
was removed, the non-invading cells of the interior of
the inserts were cleared with cotton-tipped swabs and
the inserts transferred into 500 μl of staining solution
for 20 minutes. Inserts were washed with water, air-
dried and transferred into 200 μl of extraction buffer.
The optical density of 150 μl extracted dye was mea-
sured at 560 nm. The results were evaluated using
Student’s t-test.
Quantitative real-time polymerase chain reaction (qrt-PCR)
The analysis of gene expression was carried out for 229
different genes in four main tumor associated areas:
chemokines, apoptosis, molecular mechanisms of cancer
and metastasis. Total RNA was isolated from ADSCs
and SCCs, either cultured alone or in co-culture for
four days, using the Trizol plus Kit (Life Technologies,
Carlsbad, CA, USA). The RNA-concentration was calcu-
lated by Quant-iT RNA-Assay (Life Technologies) and
1 μg was subjected to cDNA synthesis by the High Cap-
acity cDNA Reverse Transcription Kit (Life Technolo-
gies). Gene expression analysis was performed on a Step
One Plus Instrument (Life Technologies) using TaqMan
Real Time PCR technology. Gene expression was ana-
lyzed by using pre-designed TaqMan 96-well array plates
each containing 92 different genes of interest and 4 en-
dogenous controls with 10 ng cDNA per well (Human
Molecular Mechanisms of cancer #4418806, Human
Chemokines #4366072, Human Cellular Apoptosis Path-
way #4418762, Human Tumor Metastasis #4418743,
Life Technologies). In order to further investigate a
potential epithelial to mesenchymal transition (EMT)
of the cells during co-culture the gene expression of
E- and N-cadherin was analyzed using specific TaqMan
gene expression assays (Hs01023894 for E-cadherin,
Hs00983056 for N-cadherin) with 10 ng of cDNA per
sample. Calculating the difference between the cycle
threshold (CT) of the genes of interest and the CT of
the endogenous controls from the same sample provided
delta-CT values.
Human cytokine magnetic 30-plex panel
In order to quantify the level of 30 cytokines (CCL2,
CCL3, CCL4, CCL5, CXCL-9, CXCL-10, EGF, Eotaxin,
FGF-2, G-CSF, GM-CSF, HGF, IFN-α, IL-1β, IFN-γ, IL-
1ra, IL-2, IL-2r, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12,
IL-13, IL-15, IL-17, TNF-α and VEGF) and 8 differentmatrix metalloproteinases (MMP 1, 3, 7, 8, 9, 10, 12, 13)
simultaneously in samples of ADSCs monoculture, SCCs
monoculture, and ADSC-SCC-co-culture, a human cyto-
kine magnetic 30-plex (LHC6003M and LHC6002, Life
Technologies) and a human MMP magnetic Luminex
Performance Assay were conducted according to the
manufacturer’s instructions. Samples were analyzed with
a Luminex 200 instrument (BioRad). The median fluor-
escent intensity was determined and the cytokine/MMP
concentration ascertained based on the standard curves
for each cytokine/MMP.
Analysis of angiogenic properties
In order to determine the pro-angiogenic effect of
ADSCs and A-431-SCCs or the primary SCCS alone or
in co-culture, supernatants of each condition were col-
lected at Day 4 of cell culture and analyzed for induction
of tube formation in human umbilical vein endothelial
cells (HUVEC) in an in vitro angiogenesis assay kit
(Merck Millipore # ECM 625) according to the manufac-
turer’s instructions. In brief, wells of a 96-well plate were
coated with an ECM Matrix solution, and 7,500 HUVEC
cells were seeded onto the matrix in each well. The dif-
ferent conditioned media from ADSCs, A431-SCCs,
pSCCs, or ADSC-SCC-co-cultures were added and in-
cubated for 18 hours. Tube formation was visualized
with a light microscope. A positive control was induced
by Phorbol 12-myristate 13-acetate (PMA) (Abcam,
Cambridge, UK; no. ab120297).
Results
Determination of stemness
The stemness of the applied ADSCs was determined ac-
cording to the minimal consensus criteria for mesenchy-
mal stem cells [12,13] by analysis of distinct surface
markers in flow cytometry and analysis of adipogenic
and osteogenic differentiation with Oil Red and alizarin
red staining, respectively.
Flow cytometry
ADSCs were positive for CD13, CD29, CD44, CD49a,
CD63, CD73, CD90, CD105 and CD166. ADSCs were
negative for CD31, CD34, CD45 and CD106 (Figure 1).
Differentiation
Adipogenic and osteogenic differentiations were induced
to evaluate the multipotent differentiation potential. In
all donors adipogenically induced cells showed a signifi-
cantly higher oil red staining than non-induced control
cells (Figure 2a). Osteogenically differentiated ADSC
showed significantly higher extracellular calcium depos-
ition than non-induced control cells, analyzed with ali-
zarin red stain (Figure 2b). The cells, therefore, meet
Figure 1 Flow cytometry of pooled ADSCs from donors 1 to 6. Red lines show isotype controls, black lines show pooled ADSCs. ADSCs were
positive for CD13, CD29, CD44, CD49a, CD63, CD73, CD90, CD105 and CD166. ADSCs were negative for CD31, CD34, CD45 and CD106. ADSCs,
adipose tissue derived stem cells.
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Figure 2 Representative light microscopical pictures of adipogenically and osteogenically differentiated ADSCs. Magnification 10x.
(a) Intracellular lipid droplets stained by oil red method as a marker of adipogenic differentiation on Day 14 of differentiation. (b) Extracellular
calcium deposition stained with alizarin red as a marker for osteogenic differentiation on Day 42 of differentiation. Undifferentiated controls are
not shown. ADSCs, adipose tissue derived stem cells.
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cells [12,13].
Proliferation
Cell proliferation was determined by analyzing the cells’
doubling time during the exponential growth phase (in
general from days 2 to 4) (Figure 3). Data are given as
means with standard deviation (SD). Changes in cell
numbers per time are given in Figure 3.
ADSCs-A431-SCCs-co-culture
When ADSCs were cultured alone on a regular culture
surface in the six-well plate, the mean doubling time was
20 hours (SD 11), when cultured alone in a transwell in-
sert, the mean cell doubling time was 17 hours (SD 5).
A431-SCCs cultured alone in a six-well plate showed a
doubling of cell number after a mean of 17 hours (SD
7), in a transwell insert after 16 hours (SD 4). When co-
cultured in a transwell system, the growth of ADSCs on
the six-well plate significantly increased to a mean doub-
ling time of 14 hours (SD 3, P = 0.038) (Figure 3a). In
the transwell insert the growth rate of co-cultured ADSCs
slowed down to a mean doubling time of 19 hours (SD 9),
that of A431-SCCs slowed down to a mean doubling time
of 25 hours (SD 13) in the six-well plate, and to 21 hours
(SD 8) in the transwell insert (Figure 3b). These changes,
however, were not statistically significant (P >0.05).
ADSCs-pSCCs-co-culture
When ADSCs were cultured alone on a regular culture
surface in the six-well plate the mean doubling time was
26 hours (SD 8), when cultured alone in a transwell in-
sert, the mean cell doubling time was 28 hours (SD 7).
Primary SCCs cultured alone in a six-well plate showed
a doubling of cell number after a mean of 18 hours (SD
3), in a transwell insert after 21 hours (SD 6).
Co-culturing ADSCs with primary SCCs resulted in a
decreased proliferation determined by a significantlylonger doubling time in ADSCs cultured on the six-well
plate (42 hours, SD 13, P = 0.03) or in the transwell
system (51 hours, SD 25) (Figure 3c). In co-culture, pri-
mary SCCs also significantly decreased their prolifera-
tion (25 hours, SD 4, P <0.001), if cultured on the plate
(Figure 3d). If ADSCs were cultured in the transwell in-
sert, there was no significant change in proliferative ac-
tivity (22 hours (SD 4), P >0.05).Quantitative real time-PCR
Co-cultured ADSCs and SCCs (A431-SCCs and primary
SCCs) showed strong differences in the gene expression
levels compared to a mono-culture of ADSCs or SCCs.
Results were greatly similar for the two analyzed co-
culture systems (ADSCs on plate/SCCs in transwell in-
sert, and ADSCs in transwell insert/SCCs on plate). To
facilitate clear data presentation, only results of the
ADSCs on plate/SCCs in transwell insert - co-culture,
and (except for E- and N-Cadherin) changes in gene ex-
pression 2.5-fold or greater are displayed.Co-culture of A431-SCCs and ADSCs
In the ADSCs, a strong increase of the gene expression
level could be found in CSF-3 (258-fold), CXCL6 (129-
fold), IL-1β (119-fold), MMP-3 (108-fold), IL-6 (88-fold),
PTGS2 (74-fold), CXCL1 (54-fold), CCL8 (42-fold),
CSF-2 (38-fold), CCL20 (32-fold), IL-8 (29-fold), CXCL3
(27-fold), CXCL2 (16-fold), CXCL12 and IL-1α (12-fold),
CCL7 (11-fold), CCL2 and CXCL5 (9.4-fold), CCL13 (8-
fold), LYPD3 and WISP-1 (6.1-fold) and FGFR4 (5.4-fold).
To a lesser extent the expression of NR4A3 (4.7-fold),
TLR-2 (4.6-fold), CXCL11, MCAM, STAT4 and NFKBIA
(4.0-fold), MMP-2 and TYMP (3.4-fold), PIK3CD and
PPBP (3.3-fold), NFKB2 and RELB (2.7-fold), FGF2 (2.5-
fold), GPR81 (2.4 fold), TNF and CCRL1 (2.3-fold) was
also up-regulated (see Table 1, part 1 and Additional file 1:
Table S1, A, part 1).
Figure 3 Effect of ADSC-SCC-co-culture on cells’ proliferative activity. (a) The growth of ADSCs on the plate significantly increased
(P = 0.038) in co-culture with A431-SCCs in the transwell insert compared to mono-culture. The growth of co-cultured A431-SCCs in the
transwell insert was not significantly affected (P >0.05). (b) ADSC-SCC-co-culture with A431-SCCs on the six-well plate and ADSCs in the
transwell insert did not significantly affect cell growth of both cell types (P >0.05). (c) ADSC-SCC-co-culture with ADSCs on the six-well plate
and pSCCs in the transwell insert significantly reduced ADSCs’ growth compared to mono-culture (P = 0.03). The proliferative activity of
pSCCs in co-culture was not affected (P >0.05). (d) ADSC-SCC-co-culture with pSCCs on the six-well plate and ADSCs in the transwell insert
significantly decreased the growth of pSCCs (P <0.001), that of co-cultured ADSCs was not significantly affected (P >0.05). ADSC, adipose
tissue derived stem cells; SCCs, squamous cell carcinoma cells.
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following genes were strongly up-regulated in the A431-
SCCs: MMP-3 (191-fold), N-Cadherin (97-fold), HGF
(20-fold), TWIST1 (11-fold), ITGB3 (10-fold), MMP-1
(9.4-fold), and others to a lesser extent: MMP-7 (4.8-fold),
CTSK (4.1-fold), MMP-2 (3.1-fold), CYCS (3-fold), PTGS2
(2.7-fold), PPBP, IKBKE and ETV4 (2.5-fold), CCL20
and FN1 (2.4-fold) and MCAM (2.3-fold). In addition,N-Cadherin-expression in A431-SCCs is strongly up-
regulated in co-culture (71-fold) while there is no sig-
nificant change in co-cultured ADSCs (1.1-fold).
ADSCs did not express E-Cadherin in mono-culture; in
co-culture however, E-Cadherin expression was strongly
up-regulated. In co-cultured A431-SCCs, E-Cadherin
was slightly down-regulated (1.2-fold). Furthermore, the
expression of CXCL9 (4.4-fold), CXCL10 (4.8.-fold), FOS
Table 1 Changes in the gene expression levels of ADSCs







Part 1. Changes in the gene expression of ADSCs
E-Cadherin n.d. → EMT, i, m, ms
N-Cadherin 1.0 (0.0) → EMT
CCL2 9.4 (5.0) ↑ a, i, m, ms, p, EMT
CCL7 11 (3.8) ↑ a, i, m, ms, p
CCL8 42 (15) ↑ a, i, m, p
CCL13 8.0 (0.0) ↑ a, i, m, p
CCL20 32 (23) ↑ im
CSF-2 38 (20) ↑ a, i, m
CSF-3 258 (2.3) ↑ im
CXCL1 54 (16) ↑ a, i, m, ms, p
CXCL2 16 (0.0) ↑ a, i, m
CXCL3 27 (7.8) ↑ a, i, m
CXCL5 9.4 (5.0) ↑ a, i, m
CXCL6 129 (0.2) ↑ a, i, m, ms, p
CXCL11 4.0 (0.0) ↑ a, i, m
CXCL12 12 (5.7) ↑ a, i, m
IL-1α 12 (5,6) ↑ a, ms
IL-1β 119 (100) ↑ a, ms
IL-6 88 (84) ↑ p
IL-8 29 (25) ↑ a
LYPD3 6.1 (2.9) ↑ i, ms
MMP-3 108 (32) ↑ m, i, ms
NR4A3 4.7 (2.8) ↑ p
PTGS2 74 (39) ↑ a, i, im, m, ms, p
TLR-2 4.6 (2.5) ↑ a, m, i








Part 2. Changes in the gene expression of A431-SCCs
E-Cadherin * ↓↓ EMT, i, m, ms
N-Cadherin 98 (2.3) ↑ EMT
CXCL9 4.4 (0.2) ↓ a
CXCL10 4.8 (0.1) ↓ a
CTKS 4.1 (2.9) ↑ m, i, ms
FN1 2.5 (1.3) ↑ m, i
HGF 20 (12) ↑ a, m, i,
ITGB3 10 (5.1) ↑ m, i, ms
MMP-1 9.4 (5.1) ↑ m, i, ms
MMP-2 3.1 (1.5) ↑ m, i, ms
MMP-3 191 (89) ↑ m, i, ms
MMP-7 4.8 (2.4) ↑ m, i, ms
Table 1 Changes in the gene expression levels of ADSCs
and A431-SCCs in co-culture compared to mono-culture
(Continued)
MMP-9 3.4 (0.2) ↓ m, i, ms
PTGS2 2.7 (0.8) ↑ a, i, im, m, ms, p
TWIST-1 11 (3.8 ) ↑ ms
*In co-culture with ADSCs E-Cadherin expression is down-regulated in primary
SCC to undetectable levels.
GUSB was used as referring housekeeping-gene. Except for E- and N-Cadherin
only changes of 2.5-fold or higher are displayed. Part 1 displays the changes in
the gene expression levels of ADSCs. Part 2 shows the changes in the gene ex-
pression levels of A431-SCCs. Arrows mark an up- (↑) or down-regulation (↓) of
the gene expression compared to the referring mono-culture. Abbreviations of
main impact: a, angiogenesis; i, invasion, im, impaired anti-tumor response; m,
migration; ms, metastasis; p, proliferation.;Furthermore a mild down-regulation
of E2F1 (3.2-fold), CCND1, CCND3, CYCS and DVL1 (2.7-fold) and SPP1 (2.6-fold)
could be determined.
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http://stemcellres.com/content/5/3/65(4-fold), MMP-9 (3.4-fold) and PMAIP1 (3.1-fold) was
also down-regulated (see Table 1, part 2 and Additional
file 1: Table S1, A, part 2).
Co-culture of primary SCCs and ADSCs
In the ADSCs a strong increase of the gene expression
level could be found in IL-6 (65-fold), CXCL6 (64-fold),
CSF-3 (63-fold), IL-8 and CCL20 (32-fold), CCL28 (27-
fold), PTGS2 (22-fold), TLR-2 (21-fold), WISP-1 (20-fold),
CCL5, CXCL1, CXCL3 and IL-1β (16-fold), MMP-3, IL-
1α and CSF-2 (13-fold), CXCL5 (8.1-fold), VEGFA (6.7),
KISS1R (5.6-fold), CXCL14, ITGA2B and SERPINE (5.4-
fold). To a lesser extent the expression of CCL2 and
CXCL2 (4-fold), CCL7, CCL8 and PIK3CD (3.4-fold),
CXCR4 (3.1-fold), CXCL11, CXCL12, CCL3, CCL13,
FGFR4, MMP-2, MMP-9 and TPBG (2.7-fold) was also
up-regulated (see Table 2, part 1 and Additional file 1:
Table S1, B, part 1). ADSCs did not express E-Cadherin
in mono-culture, and it could not be determined in co-
cultured ADSCs either. There was no significant change
of N-Cadherin-expression in ADSCs in co-culture (1.1-
fold). A mild down-regulation of FOS and BCL2 (3-fold)
could be determined.
When primary SCCs were co-cultured with ADSCs
the CCND2 gene was up-regulated (4.7-fold) and the
following genes were down-regulated: TNF (2.7-fold)
and CCL5 (3.0-fold) (see Table 2, part 2 and Additional
file 1: Table S1, B, part 2). E-Cadherin-expression and
N-Cadherin gene expression was not significantly changed
during co-culture with ADSCs (1.5-fold, and 3.0-fold).
Multiplex protein analysis
Co-culture of A431-SCCs and ADSCs
When ADSC were co-cultured with A431-SCCs cells (see
Table 3), a very strong increase in the protein concentra-
tion in the conditioned medium could be detected for
G-CSF (357-fold), INF-α (118-fold), GM-CSF (106-fold),
MMP-9 (45-fold), IL-6 (43-fold), MMP-3 (6.8-fold), and
Table 2 Changes in the gene expression levels of ADSCs and pSCCs in co-culture compared to mono-culture
Gene Fold ADSC mono-/co-culture Up-/down-regulation Main impact of gene or gene product
Part 1. Changes in the gene expression of ADSCs
E-Cadherin n.d. n.a. EMT, i, m, ms
N-Cadherin 0.9 (0.0) → EMT
CCL5 16 (0.1) ↑ a, i, ms, p
CCL20 32 (0.4) ↑ im
CCL28 27 (7.6) ↑ a, i, ms, p
CSF-2 13 (4,3) ↑ a, i, m
CSF-3 63 (0.2) ↑ im
CXCL1 16 (0.0) ↑ a, i, m, ms, p
CXCL2 4.0 (0.0) ↑ a, i, m
CXCL3 16 (0.1) ↑ a, i, m
CXCL5 8.1 (0.0) ↑ a, i, m
CXCL6 64 (0.2) ↑ a, i, m, ms, p
CXCL14 5.4 (1.9) ↑ a
IL-1α 13 (3.7) ↑ a, ms
IL-1β 16 (0.1) ↑ a, ms
IL-6 65 (0.8) ↑ p
IL-8 32 (0.7) ↑ a
ITGA2B 5.4 (1.9) ↑ m, i, ms
KISS1R 5.6 (2.0) ↑ ms
MMP-3 13 (3.8) ↑ m, i, ms
PTGS2 22 (7.8) ↑ a, i, im, m, ms, p
SERPINE1 5.4 (2.0) ↑ i, a, m
TLR-2 21 (7.6) ↑ a, ms
VEGFA 6.7 (1.9) ↑ a
WISP-1 20 (12) ↑ m, im
Gene Fold primary SCC mono-/co-culture Up-/down-regulation Main impact of gene or gene product
Part 2. Changes in the gene expression of primary SCCs
E-Cadherin 1.5 (0.1) → EMT, i, m, ms
N-Cadherin 3.0 (0.0) ↓ EMT
CCND2 4.7 (3.9) ↑ i
GUSB was used as the referring housekeeping-gene. Except for E- and N-Cadherin only changes of 2.5-fold or higher are displayed. Part 1 displays the changes in
the gene expression levels of ADSCs. Part 2 shows the changes in the gene expression levels of pSCCs. Arrows mark an up- (↑) or down-regulation (↓) of the gene
expression compared to the referring mono-culture. Abbreviations of main impact: a, angiogenesis; i, invasion; im, impaired anti-tumor response; m, migration;
ms, metastasis; p, proliferation.
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http://stemcellres.com/content/5/3/65CCL2 (8-fold). VEGF (6.0-fold), MMP-10 (3.4-fold), INF-γ
(3.9-fold), CCL4 (3.5-fold), IL-7 (4.9-fold), IL-8 (5.4-fold),
IL-13 (3.5-fold) and IL-12 (2.8-fold) were only moderately
increased. The concentrations of bFGF, CCL3, CXCL10,
Eotaxin, HGF, IL-4, IL-10, IL-15, IL-17, MMP-1 and
TNF-α were not significantly changed compared to the
mono-culture of ADSCs (<2.5-fold change).
Exclusively in co-culture ADSCs were exposed to
CXCL9 (441 pg/ml, SD 24), IL-1β (11 pg/ml, SD 4.9),
IL-1Ra (687 pg/ml (SD 65)), IL-2R (50 pg/ml, SD 31)
and MMP-7 (131 pg/ml, SD 42).With regard to A431-SCCs mono-culture, the co-
culture with ADSCs led to a very strong increase in
MMP-3 (1527-fold), MMP-1 (143-fold), IL-6 (301-fold),
CCL2 (126-fold), HGF (118-fold), G-CSF (29-fold),
MMP-10 (17-fold), MMP-9 (13-fold), and IL-8 (13-fold),
and a moderate increase of CCL4 (7.4-fold), INF-α (6.7-
fold), IL-7 (3.0-fold) and VEGF (2.8-fold). Compared to
a A431-SCC-mono-culture, co-culturing with ADSCs
did not significantly change the concentration of bFGF,
CCL3, CXCL10, Eotaxin, GM-CSF, IL-1β, IL-4, IL-10,
IL-12, IL-13, IL-15, IL-17, IL-1Ra, IL-2R and TNF-α. In









bFGF 4.7 (1.8) 7.8 (1.6) 7.5 (2.0) 1.6 - → 1.0 - →
CCL2 2,498 (821) 168 (23) 21,096 (4,041) 8.5 - ↑ 126 - ↑
CCL3 24.1 (1.4) 22.4 (1.9) 39.2 (2.9) 1.6 - → 1.7 - →
CCL4 5.8 (3.6) 2.7 (2.5) 20 (2.7) 3.5 - ↑ 7.4 - ↑
CCL5 n.d. 13 (2.5) n.d. - - → - -↓
CXCL9 n.d. n.d. 411 (24) - - ↑ - - ↑
CXCL10 4.9 (0.3) 4.6 (0.1) 6.4 (0.3) 1.3 - → 1.2 - →
Eotaxin 1.7 (0.1) 1.6 (0.3) 1.8 (0.6) 1.1 - → 1.2 - →
G-CSF 98 (19) 1,225 (135) 34,941 (4,830) 357 - ↑ 29 - ↑
GM-CSF 1.3 (0.2) 100 (8.9) 133 (28) 106 - ↑ 1.3 - →
HGF 6,892 (1,788) 34 (15) 4,049 (746) 0.6 - → 118 - ↑
IL-1b n.d. 6.1 (3.2) 11 (4.9) - - ↑ 1.8 - →
IL-2 5.6 (1.4) 5.9 (0.8) 6.2 (0.9) - - → - - →
IL-4 22 (1.3) 19 (0.7) 31 (1.8) 1.4 - → 1.6 - →
IL-6 313 (80) 45 (4.1) 13,563 (917) 43 - ↑ 301 - ↑
IL-7 20 (7.5) 33 (8.3) 100 (19) 4.9 - ↑ 3.0 - ↑
IL-8 9,213 (3,483) 3,898 (404) 49,441 (1,572) 5.4 - ↑ 13 - ↑
IL-10 7.3 (0.3) 7.8 (0.3) 16 (0.6) 2.2 - → 2.0 - →
IL-12 27.4 (8.0) 35.2 (7.8) 76 (5.1) 2.8 - ↑ 2.2 - →
IL-13 18 (1.0) 20 (1.3) 27 (1.1) 3.5 - ↑ 1.4 - →
IL-15 36 (11) 38 (19) 33 (20) 0.9 - → 0.9 - →
IL-17 11.2 (0.7) 9.6 (0.7) 14 (1.2) 1.3 - → 1.5 - →
IL-1Ra n.d. 1,084 (82) 687 (65) 0.6 - → 0.6 - →
IL-2R n.d. 109 (0.0) 50 (31) - - ↑ 0.5 - →
INF-α 84 (16) 40 (5.4) 268 (14) 118 - ↑ 6.7 - ↑
INF-γ 2.3 (0.9) 5.7 (1.4) 8.8 (2.4) 3.9 - ↑ 1.5 - →
MMP-1 33,056 (5,448) 302 (33) 43,274 (15,154) 1.3 - → 143 - ↑
MMP-3 16,089 (3,424) 72 (7) 109,950 (47,520) 6.8 - ↑ 1,527 - ↑
MMP-7 n.d. n.d. 131 (42) - - ↑ - - ↑
MMP-9 156 (18) 533 (57) 6,987 (15,036) 45 - ↑ 13 - ↑
MMP-10 357 (67) 70 (2.3) 1,202 (333) 3.4 - ↑ 17 - ↑
TNF-α 2.7 (1.3) 2.5 (1.0) 4.1 (2.0) 1.5 - → 1.7 - →
VEGF 61 (11) 132 (22) 362 (40) 6.0 - ↑ 2.8 - ↑
CXCL9 and MMP-7 could only be detected in co-culture. Standard deviation is given in brackets. Results from 0 to 9.9 are shown with one decimal, results 10 or
higher are displayed without decimals. n.d., not detectable; − −, not applicable.
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http://stemcellres.com/content/5/3/65contrast to that, CCL5 was down-regulated to a no lon-
ger detectable level in co-cultured A431-SCCs.
CXCL-9 (411 pg/ml, SD 24) and MMP-7 (131 pg/ml,
SD 42) were exclusively produced in co-culture but nei-
ther in the mono-culture of A431-SCCs nor of ADSCs.
Co-culture of primary SCCs and ADSCs
When ADSCs were co-cultured with primary SCCs cells
(see Table 4), a strong increase in the protein concentrationin the conditioned medium could be detected for G-CSF
(77-fold) and GM-CSF (10-fold), and a moderate increase
for IL-6 (5.5-fold), CCL4 (3.8-fold), IL-7 (3.4-fold), IL-8
(3.0-fold) and IL-2 (2.5-fold). Exclusively in co-culture,
ADSCs were exposed to CCL5 and CXCL9.
For ADSCs, no major changes in the protein level
of bFGF, CCL2, CCL3, CXCL10, Eotaxin, MMP-1,
MMP-3, MMP-9, MMP-10, HGF, INF-α, INF-γ, IL-4,
IL-10, IL-12, IL-13, IL-17, TNF-α and VEGF (<2.5-fold









bFGF 3.9 (1.9) 5.3 (1.1) 6.6 (1.8) 1.7 - → 1.3 - ↑
CCL2 2,768 (109) 565 (83) 5,707 2.1 - → 10 - ↑
CCL3 26 (1.7) 25 (1.5) 32 (4.6) 1.2 - → 1.3 - →
CCL4 2.9 (2.0) 2.0 (0.0) 11 (4.9) 3.8 - ↑ 5.4 - ↑
CCL5 n.d. 216 (32) 95 (8.4) - - ↑ 0.4 - →
CXCL9 n.d. n.d. 208 (14) - - ↑ - - ↑
CXCL10 4.7 (0.2) 5.7 (0.5) 7.0 (0.8) 1.5 - → 1.2 - →
Eotaxin 1.7 (0.4) 1.8 (0.3) 2.1 (0.2) 1.3 - → 1.2 - →
GM-CSF 1.0 (0.1) 13 (0.9) 32 (4.6) 10 - ↑ 0.8 - →
G-CSF 40 (23) n.d. 3,076 (330) 77 - ↑ - - ↑
HGF 6,125 (317) 72 (31) 3,661 (174) 0.6 - → 51 - ↑
IL-1b n.d. n.d. 6.2 (1.2) - - ↑ - - ↑
IL-2 4.7 (0.7) 5.4 (0.6) 5.2 (0.9) 2.5 - ↑ 1.0 - →
IL-4 22 (0.9) 21 (0.6) 29 (2.1) 1.3 - → 1.4 - →
IL-6 349 (40) 4.0 (1.4) 1,912 (396) 5.5 - ↑ 480 - ↑
IL-7 16 (1.2) n.d. 53 (23) 3.4 - ↑ - - ↑
IL-8 11,219 (652) 8,825 (791) 34,032 (1,805) 3.0 - ↑ 3.9 - ↑
IL-10 7.3 (0.0) 6.4 (0.6) 9.5 (0.7) 1.3 - → 1.5 - →
IL-12 28 (5.1) 29 (6.0) 54 (11) 1.9 - → 1.9 - →
IL-13 18 (1.6) 15 (0.8) 20 (3.0) 1.1 - → 1.4 - →
IL-17 11 (1.1) 10 (0.6) 14 (1.4) 1.3 - → 1.4 - →
INF-α 102 (5.6) 61 (6.6) 156 (12) 1.5 - → 2.6 - ↑
INF-γ 2.2 (0.5) 3.0 (1.4) 6.1 (3.5) 1.6 - → 1.0 - →
MMP-1 44,830 (2,372) n.d. 24,473 (1,564) 1.8 - → - - ↑
MMP-3 2,288 (268) 47 (2.6) 4,354 (386) 1.9 - → 92 - ↑
MMP-9 110 (5.2) 275 (19) 174 (11) 1.6 - → 1.6 - →
MMP-10 149 (14) 17 (3.5) 248 (13) 1.7 - → 14 - ↑
TNF-α 2.1 (0.5) 3.2 (0.9) 3.2 (1.9) 1.6 - → 1.0 - →
VEGF 63 (8.7) 26 (8.1) 117 (30) 1.9 - → 4.6 - ↑
CXCL9 and IL-1β could only be detected in co-culture. Standard deviation is given in brackets. Results from 0 to 9.9 are shown with one decimal, results 10 or
higher are displayed without decimals. n.d., not detectable, − −, not applicable.
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mono-culture.
With regard to SCCs mono-culture, the co-culture with
ADSCs led to a very strong increase in IL-6 (480-fold),
MMP-3 (92-fold), HGF (51-fold), MMP10 (14-fold), CCL2
(10-fold), and a moderate increase in CCL4 (5.4-fold),
VEGF (4.6-fold), IL-8 (3.9-fold) and INF-α (2.6).
Compared to a pSCC-mono-culture, co-culturing with
ADSCs did not significantly change the concentration of
bFGF, CCL3, CCL5, CXCL10, Eotaxin, GM-CSF, IL-2,
IL-4, IL-10, IL-12, IL-13, IL-17, IL-1Ra, IL-2R, INF-γ,
MMP-9 and TNF-α (<2.5-fold change).
Exclusively in co-culture, primary SCCs were exposed
to IL-7 (53 pg/ml, SD 23), G-CSF (3,076, SD 330) and
MMP-1 (24,473 pg/ml, SD 1,564).CXCL-9 (208 pg/ml, SD 14) and IL-1β (6.2 pg/ml, SD
1.2) were exclusively produced in co-culture of ADSCs and
primary SCCs but not in mono-culture of both cell types.
Migration
The migration through the transwell pores could already
be detected when ADSC, A431-SCCs, or primary SCCs
were cultured alone; however, when co-cultured with
A431-SCCs the migration of ADSC was significantly in-
creased about 17% (P = 0.012), while that of the A431-
SCCs was not changed compared to the mono-culture
(P >0.05) (Figure 4a). In co-culture with ADSCs the mi-
gratory capacity of the primary SCCs was also signifi-
cantly increased by about 15% (P = 0.009) while that of
the ADSCs remained unchanged (Figure 4b).
Figure 4 Migration assay. a) Migratory capacity of the ADSCs (black bar) and A431-SCCs (red bar) alone and in co-culture, measured as the level
of optical density at 560 nm, with a standard deviation (SD). When co-cultured with A431-SCCs (black bar with red checkerboard pattern) ADSCs
showed a significantly higher migration as in mono-culture (P = 0.014). Co-culture of A431-SCCs with ADSCs (red bars with black diagonal slashes)
does not lead to a significant change in the migratory properties of A431-SCCs (P >0.05). b) Migratory capacity of the ADSCs (black bar) and
pSCCs (yellow bar) alone and in co-culture, measured as the level of optical density at 560 nm, with a SD. When co-cultured with pSCCs (black
bar with yellow checkerboard pattern) ADSCs showed a higher migration as in mono-culture (P >0.05). Co-culture of pSCCs with ADSCs (yellow
bars with black diagonal slashes) resulted in a significantly increased migration of pSCCs (P = 0.009). ADSC, adipose tissue derived stem cells;
pSCCs, primary squamous cell carcinoma cells; SCCs, squamous cell carcinoma cells.
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ADSCs and A431-SCCs showed invasive behavior by
actively digesting the extracellular matrix blocking the
transwell pores and migrating to the lower surface of
the transwell inserts’ floor. This was significantly in-
creased by a mean of 33% in the co-cultures for ADSCs
(P = 0.014) and significantly increased by a mean of 35%
for SCCs (P <0.001), respectively (Figure 5a). When co-
culturing primary SCCs with ADSCs the invasive behavior
of the primary SCCs was significantly increased by a mean
of 33% compared to the culture of primary SCCs alone
(P = 0.038). The invasive behavior of ADSCs in this
context was not changed by co-culturing with primary
SCCs (Figure 5b).
Angiogenesis
Tube formation could be detected after incubation of
HUVEC cells with conditioned media from co-cultured
ADSC-A431-SCCs and slightly from co-cultured ADSCs-
pSCCs, and mono-cultured ADSCs or A431-SCCs. No
significant angiogenesis could be detected when condi-
tioned media from pSCC- or A431-SCC-mono-culture
was added to the system (Figure 6).
Discussion
ADSCs are a promising future tool in skin regenerative
medicine, providing many so far suggested positive effects,
such as increasing the dermal collagen content, support-
ing neoangiogenesis or inhibiting melanin synthesis andthe activity of skin matrix degrading enzymes [1,3-5,14].
These effects are mainly due to the paracrine activity of
the transplanted stem cells, reflecting the reaction of the
surrounding cells, such as dermal fibroblasts or melano-
cytes, towards secreted cytokines and growth factors. In
vivo, however, there is always a risk of malignant cells be-
ing present in the vicinity of the transplanted ADSCs.
These malignant cells would also be in direct contact with
the released proteins, and thus, prone to be influenced by
the ADSCs secretome. Nevertheless, research about the
possible interactions of ADSCs and skin tumor cells is still
not in the focus of most skin regeneration projects. The
present study is the first to show that the co-culture of
human SCCs and human ADSCs leads to a significant
change in the gene expression profile of both cell types,
as well as a remarkable change in the secreted protein
levels. Additionally, ADSCs increased their migration
towards SCCs, and invasiveness rose in both cell types,
with the latter being an important indicator for a pos-
sible rise of local destruction and occurrence of metas-
tases. Furthermore, some proteins, such as MMP-7,
IL-1β or CXCL9, were exclusively produced in ADSC-
(p)SCC-co-culture, but not in mono-culture. These
aforementioned changes in protein and gene expression
strongly point towards important adverse biological con-
sequences that may arise in case of the in vivo co-
presence of ADSCs and SCCs.
In co-culture the gene expression or protein synthesis
of a couple of pro-angiogenic proteins, such as FGF-2,
Figure 5 Invasion assay. a) Invasive behavior of ADSCs (black bar) and A431-SCCs (red bar) alone and in co-culture, measured as the level of
optical density at 560 nm with a standard deviation (SD). When co-cultured with A431-SCCs (black bar with red checkerboard pattern) ADSCs
showed a significantly higher invasive capacity as in mono-culture (P = 0.014). Co-culture of SCCs with ADSCs (red bars with black diagonal
slashes) also leads to a significant increase in the invasive behavior of A431-SCCs (P <0.001). b) Invasive behavior of ADSCs (black bar) and pSCCs
(yellow bar) alone and in co-culture, measured as the level of optical density at 560 nm, with a SD. When co-cultured with pSCCs (black bar with
yellow checkerboard pattern) ADSCs did not significantly change their invasive capacity compared to mono-culture. Co-culture of pSCCs with
ADSCs (yellow bars with black diagonal slashes), however, leads to a significant increase in the invasive behavior of pSCCs (P = 0.013). ADSC,
adipose tissue derived stem cells; pSCCs, primary squamous cell carcinoma cells; SCCs, squamous cell carcinoma cells.
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http://stemcellres.com/content/5/3/65IL-8, VEGF, CCL2 and CXCL6, is strongly up-regulated
in ADSCs and/or SCCs. They are all known to support
neoangiogenesis by increased migration and mitosis of
endothelial cells, formation of new capillaries and vessel
fenestrations or inhibition of endothelial cell apoptosis
[15-26]. By supplying nutrition, this is an important
component of tumor growth. Fittingly, we found an
increased angiogenic potential in ADSC-A431-SCC-co-
culture compared to respective mono-cultures in vitro.
Several of these angiogenic proteins lead to an enhanced
secretion of metalloproteinases and an increased MMP-
activity, which not only facilitates neoangiogenesis, but
also degradation of extracellular matrix and thereby in-
vasive tumor growth. In contrast to that, the angiostatic
CXCL-9 and CXCL10 [27] are down-regulated in co-
culture or only expressed at a very low level.
IL-6 gene expression is highly up-regulated in ADSCs
co-cultured with A431- and primary SCCs and the IL-6
protein level significantly increased in the co-culture
medium, too. IL-6 has been reported to be a proliferative
factor for diverse tumor types in vivo [28-30], and ele-
vated serum levels of IL-6 have been associated with key
features of malignancy, cancer progression and a poor
clinical outcome in different types of cancers [31-37].
Presumably, one part of these IL-6 effects is achieved
by increasing TWIST-expression, as well as stabilizing
TWIST and inhibiting its degradation, thereby increasing
cell motility and tumor progression [32]. TWIST1 en-
codes for the TWIST-related protein 1, a transcription
factor, which acts as an oncogene in several cancers andhas been shown to be involved in the development of re-
sistance towards chemotherapeutic drugs and evading
apoptosis [38]. When co-cultured with ADSCs TWIST1
was also significantly up-regulated in A431-SCCs cells
in our experiment. TWIST1 plays a role in metastasis,
presumably through up-regulation of MMP-expression
and inhibition of tissue inhibitor of metalloproteinases-1
expression [39,40]. Indeed, the gene expression or pro-
tein synthesis of matrix metalloproteinases, such as
MMP-1, −2, −3 or −7, was highly up-regulated when
ADSCs and A431- or primary SCCs were co-cultured. In
fact, MMP-7 was solely produced in co-culture but not
in mono-culture. MMPs contribute to the breakdown of
extracellular matrix in a multitude of physiological and
pathological processes (for example, connective tissue
remodeling, wound repair and metastasis). We could
show a corresponding significant increase in the invasive
behavior of primary SCCs and A431-SCCs and ADSCs,
in the co-culture. Altered MMP expression has already
been linked with poor disease prognosis in different hu-
man cancers and enhanced cancer cell invasion [41,42].
In addition to that, the CTKS gene expression was
up-regulated in co-cultured A431-SCCs. CTKS encodes
for cathepsin K, a cysteine protease with strong collage-
nolytic and elastolytic properties which is involved in
extracellular matrix turnover [43,44]. CTKS up-regulation
has been associated with tumor progression in squamous
cell carcinomas of the skin [43].
Regarding the extracellular matrix (ECM), the expression
of the fibronectin 1 gene FN1 was slightly up-regulated
Figure 6 Induction of angiogenesis. Angiogenesis assay with incubation of HUVEC cells with conditioned media from mono-cultured ADSCs
(a, e), A431-SCCs (b), pSCCs (f), co-cultured ADSC-A431-SCCs (c), and co-cultured ADSCs-pSCCs (g). Controls (d, h) were induced with PMA.
Tube formation could be detected with conditioned media from co-cultured ADSC-A431-SCCs, slightly from co-cultured ADSCs-pSCCs, and
mono-cultured ADSCs or A431-SCCs. No significant angiogenesis could be detected when conditioned media from pSCC- or A431-SCC-mono-
culture was added to the system. ADSC, adipose tissue derived stem cells; HUVEC, human umbilical vein endothelial cells; PMA, phorbol
12-myristate 13-acetate; pSCCs, primary squamous cell carcinoma cells; SCCs, squamous cell carcinoma cells.
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regulation in tumor cells has been associated with
radioresistance, tumor progression and metastatic out-
growth [45-47]. Presumably, together with other extra-
cellular matrix proteins, fibronectin forms a complex
network around the tumor cells, regulating cell adhesion,
migration and proliferation of tumor cells, fibroblasts and
endothelial cells [48,49]. Integrins can bind fibronectin
and are crucial in different tumor-associated processes,
such as tumor cell growth, angiogenesis and metastasis.
Co-culture strongly up-regulated the ITGA2B (integrin
alpha 2 beta)-expression in ADSCs and ITGB3 (integrin
beta 3) gene expression in A431-SCCs. Increased ITGB3
expression has been linked to an increase in migration
and invasion, as well as a more aggressive phenotype
of tumor cells, a progressed tumor grade and a poor
prognosis [50,51].
Furthermore, ADSC-SCC-co-culture resulted in a very
strong up-regulation of the gene expression of CSF-2
and −3 which resulted in a corresponding extraordinary
increase in G-CSF and a moderate increase in GM-CSF
concentration in the co-culture media. In general, G-
CSF is associated with the stimulation of granulocytes
and the proliferation of immature hematopoietic precur-
sor cells during inflammatory responses. Tumor-derived
G-CSF, however, has been demonstrated to be able to
enhance tumor growth by inducing myeloid-derived
suppressor cells, which suppress innate and adaptive
immunity [52]. Thus, the increase in G-CSF by co-
culturing ADSCs with SCCs might be associated with
an increased tumor growth in vivo. Enhanced GM-
CSF-levels in tumors are associated with a reduced cellproliferation but an increased migratory capacity, an in-
creased tumor cell invasion by elevating MMP expres-
sion, and a higher vessel density [53]. This might be an
explanation for the significantly reduced proliferation in
co-cultured primary SCCs in our experiment.
Cancers often arise in association with a long lasting
chronic inflammation [54]. High expression of some in-
terleukins, such as IL-1α and IL-1β, has been associated
with a more aggressive tumor type and poor prognosis
[55-57]. ADSCs-SCCs-co-culture - both, with A431-
SCCs and primary SCCs, led to a strong increase in IL-
1α and β gene expression in ADSCs. IL-1β could only be
detected in co-culture and not in mono-culture of
ADSCs or primary SCCs. Both proteins, IL-1α and -β,
have been implicated in tumor progression by inducing
the expression of angiogenic and metastatic genes, cyto-
kines and growth factors, such as MMPs, VEGF, IL-6
and 8, CCl2, CCL7, TNFα and TGFβ [58-60]. Import-
antly, IL1-β also stimulates an increase in prostaglandin
E2 production through cyclooxygenase-2 (COX-2) in-
duction. The highly up-regulated PTGS2 gene in co-
cultured ADSCs and also in A431-SCCs, encoding for
COX-2, further supports this. All essential steps of ma-
lignant tumor progression, such as mutagenesis, mito-
genesis, angiogenesis, reduced apoptosis, metastasis and
immunosuppression, are associated with prostaglandin 2
[61]. Furthermore, it has been shown that infiltrates of
immune cells and expression of inflammatory mediators,
for example, cytokines and chemokines, are an import-
ant part of the tumor milieu and substantially contribute
to tumor development and progression [62]. In this con-
text, it is important to see that there is a robust up-
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ample, CCL2, CCL3, CCL4, CCL5, CCL7, CCL8, CCL13,
CCL20, CCL28, CXCL1, CXCL2, CXCL3, CXL5, CXCL6,
CXCL11, CXCL12 and CXCL14 in ADSCs co-cultured
with primary or A431-SCCs. CXCL9 expression can only
be detected in co-culture. In tumors these chemokines
attract special leukocyte/monocyte subpopulations - for
example, tumor associated macrophages - which can pro-
mote tumor growth and metastasis by stimulating angio-
genesis, ECM-degradation and tumor cell proliferation
[63-66]. High numbers of these macrophages present at
the tumor site have been associated with poor prognosis
and disease progression [67]. CCL2 additionally promotes
epithelial to mesenchymal transition and is linked to can-
cer cell migration and cancer progression [65,68]. In line
with that, E-Cadherin was strongly down-regulated and
N-Cadherin strongly up-regulated in co-cultured A431-
SCCs, suggesting an epithelial-mesenchymal transition.
E-Cadherin is an important cell-cell adhesion molecule in
epithelial cells. Its down-regulation has not only been im-
plicated in epithelial-mesenchymal transition, but also in
an increase in cellular motility, invasion and metastasis.
There is an inverse correlation among E-cadherin levels,
tumor grade and patient mortality rates [69].
Different C-C motif ligand-chemokines (CCL) and C-
X-C motif ligand chemokines (CXCL), such as CCL2,
CCL7, CXCL1 and CXCL6, are also potent stimulators
of pro-malignant features, such as tumor cell prolifera-
tion, migration and invasion, as well as angiogenesis.
They promote tumor growth, facilitate metastasis, and
high serum levels are associated with a poor outcome
[60,66,70-73]. However, it is important to say that post-
transcriptional modifications are common for many che-
mokines, affecting their biological function [74]. Thus,
the up-regulation of their gene expression does not ne-
cessarily lead to a one-to-one change in protein activity
and in vivo function.
In addition, HGF gene expression was strongly in-
creased in co-cultured A431-SCCs, and also primary
SCCs were exposed to a highly increased hepatocyte
growth factor (HGF) level in co-culture compared to
monoculture, due to high expression of HGF by ADSCs.
HGF is known to be a potent angiogenic factor and to
be associated with a more advanced tumor stage in dif-
ferent malignancies in vivo [75]. Furthermore, it has
been demonstrated that HGF significantly increases the
migration and invasion of esophageal SCCs in vitro, and
that it is a major component of tumor progression in-
duced by tumor-associated fibroblasts [76,77]. Thus, an
increased HGF level in the ADSC-SCCs microenviron-
ment, as shown in our experiment, might also promote
tumor progression in an in vivo setting.
Other important genes were also up-regulated in
co-cultured ADSCs: LYPD3, WISP-1, TLR-2, and SERPINE-1. LYPD3, encoding for the Ly6/PLAUR domain-containing
membrane protein 3, has been shown to be down-regulated
upon transition to dysplasia and carcinoma in situ, and
being up-regulated again at the invasive front and in
local lymph node metastasis of esophageal squamous
cell carcinomas [78,79]. The WISP-1 gene encodes the
Wnt-induced secreted protein-1, which has been shown
to enhance tumor cell migration by increasing MMP-2
expression, and to inhibit anti-tumor immunity by block-
ing the response of immune cells to IL-12. Further-
more, it has been associated with a poor prognosis
in certain tumor types [80-82]. In addition, also, the
TLR-2 (Toll-like receptor-2) has been associated with
increased tumor progression and metastasis, as well as
tumor angiogenesis [83].
SERPINE-1 encodes for the plasminogen activator
inhibitor-1 (PAI-1) which is thought to facilitate tumor
invasion by controlling the peritumor proteolytic micro-
environment, regulating cell adhesion and migration,
and stabilizing early capillary vessel structures. Elevated
PAI-1 levels have been associated with a poor prognosis
and a reduced disease-free survival in various malignan-
cies [84,85].
Two other genes were also up-regulated in ADSCs co-
cultured with A431 or pSCCs, respectively, NR4A3 and
KISS1R. NR4A3 encodes for the orphan nuclear receptor
NOR-1, an early immediate response gene, which among
others is involved in cell growth and survival, apoptosis,
glucose and lipid metabolism, and inflammation [86-88].
KISS-1R encodes for the KiSS1-derived peptide receptor,
a G-protein-coupled receptor which is known to play
multiple roles in cancer development and metastasis
[89]. For both proteins, their distinct functions are dis-
cussed controversially in different tumor types.
The expression of the CCND2 gene, encoding for cyc-
lin D2, was up-regulated in primary SCCs co-cultured
with ADSCs. Cyclin D2 plays an important role in the
cell cycle at the transition from G1- to S-phase. High ex-
pression of CCND2 in vitro has been strongly associated
with a more invasive SCC cell type in vivo and malig-
nant progression [90,91].
Besides that, the primary SCCs gene expression did not
seem to be much altered by co-culturing with ADSCs.
Additionally, if cultured on the plate of the transwell sys-
tem, co-culture of ADSCs and pSCCs significantly low-
ered the proliferation of both cell types. However, this
should be interpreted cautiously, as it is not a sign of
lack of interaction between or a hint towards a safe co-
existence of these two cell types. The reduced cellular pro-
liferation of primary SCCs determined under certain
in vitro culture conditions might be a result of the in-
creased GM-CSF-levels [53], a temporary effect or reflect
a lack of supplemented nutrients in the in vitro situation.
A risk of increased malignant features of SCCs in close
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the tumor cells are exposed to a new or more potent
cocktail of cytokines, growth factors and matrix degrad-
ing enzymes secreted by the ADSCs. In line with that,
we could show that the co-culture with ADSCs signifi-
cantly increased the migration and invasion of primary
SCCs in vitro.
The present study is first to show numerous interac-
tions of ADSCs and a well-known and often used SCC
cell line as well as primary SCCs in vitro. The results in-
tensely point to clinically relevant consequences, such as
an increase in tumor growth and earlier or more dissem-
inated metastasis. Our results strongly support the hy-
pothesis that there is an interaction between ADSCs and
SCCs with potentially detrimental consequences for pa-
tients. To clarify the, in part, contradictory results and
to get the necessary further insight into the far more
complex situation in vivo, we are currently performing
in vivo experiments in a rodent model. Nonetheless, our
current results already need to fuel a necessary discus-
sion about the safety of ADSC-based therapies, particu-
larly in the skin.
Conclusion
In summary, ADSCs significantly affect the multiple ma-
lignant properties of SCCs, such as invasion, gene ex-
pression and protein synthesis in vitro. Thereby ADSCs
may strongly increase the risk of squamous cell carcin-
oma tumor growth and metastasis in vivo. Therefore, it
is crucial to rigorously screen all patients for pre-
malignant lesions prior to the injection of fat, stem cell-
augmented fat or isolated ADSCs in the skin or adjacent
tissues to avoid a potential co-localization of ADSCs
and SCCs. Informed consent of patients to such proce-
dures will need to include the explanation of an in-
creased risk of developing a malignant skin condition
or the faster growth and dissemination of a possibly
pre-existing skin cancer.
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